CLEVELAND, OH, Centerline Biomedical, a private medical technology company, announced the closing of a $33M Series B equity financing led by Cleveland Clinic.
Centerline Biomedical, Inc. (Centerline), a private medical technology company, announced the closing of a $33 million Series B equity financing led by Cleveland Clinic with participation by GE Healthcare, RIK Enterprises, JobsOhio, Jumpstart Ventures and G2 Group Ventures.
Centerline Biomedical, Inc. was founded in 2014 as a spinoff of the Cleveland Clinic to commercialize our innovative vascular navigation technology. With a research, development, and design history rooted in the Clinic's world-class Lerner Research Institute's Heart and Vascular Institute, the IOPS platform can be further used for predictive modeling, clinical decision support, global healthcare analytics and the education and training of future surgeons and interventionists.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about